Nippon India Nifty Pharma ETF
₹24.9748
₹0.38 (-1.48%)
NAV as of 29 May 2026
Returns (Lumpsum)
CAGR for periods ≥ 1 yearSIP Returns (XIRR)
₹1,000/month SIP, annualisedSIP since inception — what ₹500/month became
Real NAV backtest from day one
₹29,000
Invested
₹43,515
Value today
16.9%
XIRR (p.a.)
₹500/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹1,000 lumpsum at launch — value today
Invested on the fund's first NAV date
₹1,000
Invested
₹1,733
Value today
11.9%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹11,16,831
Value today
+7.4%
vs lumpsum
STP beat direct lumpsum by 7.4% — reduced timing risk paid off
Model your own STP with real NAVFund Details
Risk Metrics
Trailing 1 year, annualised0.26
Sharpe Ratio
—
Alpha
—
Beta
0.25
Sortino
16.25%
Std Dev
-15.71%
Max Drawdown
Portfolio Strategy
This is an Exchange Traded Fund (ETF) listed on Indian stock exchanges. It passively tracks an index or commodity.
ETF, FoF, and index funds track an index or target fund — not individual securities. Portfolio performance is captured via NAV and benchmark returns shown above.
Performance Comparison
Interested in This Fund?
Our experts will help you decide if this fund fits your goals.
Investment Objective
Nippon India Nifty Pharma ETF is an exchange-traded fund (ETF) that trades on stock exchanges like a regular share. It offers real-time pricing, low expense ratios, and the flexibility to buy and sell units throughout the trading day.
About This Fund
Nippon India Nifty Pharma ETF is a ETF mutual fund offered by Nippon India Mutual Fund. The fund has been operational for over 4 years. It manages assets worth ₹1,050 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY PHARMA TRI.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •Cost-conscious investors who prefer passive investing with low expense ratios
- •SIP investors who can benefit from rupee cost averaging during market fluctuations